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OBJECTIVEdImpaired insulin sensitivity increases the risk of cardiovascular disease. Al-
though calorie restriction and weight loss increase insulin sensitivity, the effects of modifying
macronutrient composition on insulin sensitivity are uncertain. The purpose of this study is to
determine the effects on insulin sensitivity of a carbohydrate-rich diet (CARB; similar to the
Dietary Approaches to Stop Hypertension [DASH] diet), a protein-rich diet (PROT; protein
predominantly from plant sources), and an unsaturated fat–rich diet (UNSAT; predominantly
monounsaturated).
RESEARCH DESIGN AND METHODSdThis study was a randomized, controlled,
three-period, crossover feeding study. The study participants were 164 individuals with prehy-
pertension or stage 1 hypertension without diabetes. Diets were administered for 6 weeks each,
with a washout period between diets of 2–4 weeks. Weight was held constant throughout the
study. For our primary outcome, we calculated the quantitative insulin sensitivity check index
(QUICKI) using the end-of-period fasting serum glucose and insulin. QUICKI is a validated
measure of insulin sensitivity. The primary analyses used generalized estimating equations.
RESULTSdAt baseline, mean (SD) BMI was 30.2 (6.1) kg/m
2, and mean (SD) QUICKI was
0.35 (0.04). The UNSAT diet increased QUICKI by 0.005, more than the CARB diet (P = 0.04).
PROT had no signiﬁcant effect compared with CARB.
CONCLUSIONSdA diet that partially replaces carbohydrate with unsaturated fat may im-
prove insulin sensitivity in a population at risk for cardiovascular disease. Given the well-rec-
ognized challenges of sustaining weight loss, our results suggest an alternative approach for
improving insulin sensitivity.
Diabetes Care 36:1132–1137, 2013
I
nsulin resistance is a physiological de-
crease in sensitivity to the actions of
insulin (1). The prevalence of insulin
resistance is dramatically increasing as a
result of the global obesity epidemic (2).
Aside from leading to type 2 diabetes, in-
sulin resistance increases the risk of car-
diovascular disease (3–5). It is well
established that daily caloric restriction
and weight loss improve insulin sensitiv-
ity (6). Whether modifying the macronu-
trient composition of diet has beneﬁcial
effects on insulin sensitivity is unclear
but may be an effective approach for in-
creasing insulin sensitivity, given the
challenges of sustaining weight loss.
We evaluated the effects of three
diets of differing macronutrient intake
on insulin sensitivity: a diet high in
carbohydrates (CARB), compared with
diets in which carbohydrate is partially
replaced with protein (PROT) and un-
saturated fat (UNSAT) (7). We assessed
changes in fasting insulin, glucose, and
the quantitative insulin sensitivity check
index (QUICKI), a fasting steady-state
index of insulin sensitivity (8). We hy-
pothesized that diets with increased
proportions of proteins and unsat-
urated fats, in comparison with a high-
carbohydrate diet, would increase insulin
sensitivity.
RESEARCH DESIGN AND
METHODSdThe Optimal Macronu-
trient Intake Trial to Prevent Heart Dis-
ease (OmniHeart) was an investigator-
initiated, National Heart, Lung, and
Blood Institute–funded trial (7). The
study methods and primary results have
been published elsewhere (7,9). In brief,
it was a randomized, three-period, cross-
over feeding study. This protocol was re-
viewed and approved by institutional
review boards at the two participating
clinical centers (The Johns Hopkins Uni-
versity medical institutions and Brigham
and Women’s Hospital).
Participants
Trial participants were adults in overall
good health, 30 years of age and older,
with either prehypertension or stage 1
hypertension (systolic blood pressure of
120–159mmHgoradiastolicbloodpres-
sure of 80–99 mmHg). The exclusion cri-
teria were preexisting diabetes; active or
priorcardiovasculardisease;LDLcholes-
terol .220 mg/dL; fasting triglycerides
.750 mg/dL; weight .350 lbs; use of
insulin, hypoglycemic agents, medica-
tions that affect blood pressure or blood
lipid levels, or vitamin and mineral sup-
plements; and self-reported alcohol in-
take of .14 drinks per week. By
design, the trial enrolled ;50% African
Americans.
ccccccccccccccccccccccccccccccccccccccccccccccccc
From the
1Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland; the
2Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland;
the
3Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins University, Bal-
timore, Maryland; the
4Division of Epidemiology, Statistics, and Prevention Research, Epidemiology
Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda,
Maryland; the
5Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts; and the
6Channing Laboratory, Department of Medicine, Harvard Medical School and Brigham and Womens’
Hospital, Boston, Massachusetts.
Corresponding author: Meghana D. Gadgil, mgadgil2@jhmi.edu.
Received 6 May 2012 and accepted 31 October 2012.
DOI: 10.2337/dc12-0869. Clinical trial reg. no. NCT00051350, clinicaltrials.gov.
© 2013 by the American Diabetes Association. Readers may use this article as long as the work is properly
cited,theuseiseducationalandnotforproﬁt,andtheworkisnotaltered.Seehttp://creativecommons.org/
licenses/by-nc-nd/3.0/ for details.
1132 DIABETES CARE, VOLUME 36, MAY 2013 care.diabetesjournals.org
Clinical Care/Education/Nutrition/Psychosocial Research
ORIGINAL ARTICLEParticipant ﬂow
Eligibility was ascertained and baseline
data were collected during three screening
visits. Participants subsequently under-
went a 6-day run-in period in which
participants ate meals from each study
diet for 2 days to ensure tolerance to study
foods. They were then randomly assigned
to one of six sequences of the three diets
through computer-generated assignments.
Each feeding period lasted 6 weeks. A
washout period of 2–4 weeks separated
the feeding periods. During the washout,
participants ate their own foods.
Study diets
The macronutrientcompositionforstudy
diets is presented in Table 1. The CARB
diet provided 58% of kilocalories from
carbohydrate, 15% from protein, and
27% from fat, and was similar to the Di-
etary Approaches to Stop Hypertension
(DASH) diet (10). The PROT diet re-
placed 10% of carbohydrate calories
with protein and provided 25% of calo-
ries from protein, 48% from carbohy-
drates, and 27% from fat. The UNSAT
diet replaced 10% of carbohydrate calo-
ries with unsaturated fats and provided
48% of calories from carbohydrates,
15% from protein, and 37% from fat.
The increase in fat in the UNSAT diet pri-
marilyresultedfromanincreaseinmono-
unsaturated fat from olive, canola, and
safﬂower oils and nuts and seeds. Each
diet provided 6% of calories from satu-
rated fat. Protein sources included meat,
poultry, egg product substitutes, and
dairy; however, most of the increase in
the PROT diet came from plant-based
sources. The type of carbohydrate in each
diet was similar, as indicated by the total
dietary glycemic index (68 in CARB diet,
71inthePROTdiet,and75inUNSATdiet,
relative to the white bread index).
Controlled feeding
For each diet, there was a 7-day menu
cycle. Calorie intake was adjusted so that
each participant maintained a constant
body weight (to within 2% of individual
baseline) during the entire study. Partic-
ipants were weighed daily. All meals and
snackswerepreparedinresearchkitchens
and provided to the participants. Partic-
ipants were asked to maintain exercise
frequency and intensity and to limit alco-
hol consumption to usual patterns.
Fasting blood samples were collected
after an 8–12-h fast at baseline and at 4
and 6 weeks of each feeding period, for
assessment of insulin and glucose levels.
They were stored at 2708C. Glucose was
measured using the enzymatic hexoki-
nase kit from Roche on the Hitachi 917.
Insulinwasmeasuredusingmicroparticle
enzyme immunoassay technology on the
Abbott IMx analyzer. To enhance preci-
sion, we averaged the values taken at 4
and 6 weeks to produce one intervention
value for each diet in each participant.
Indices of insulin sensitivity
We assessed insulin sensitivity by calcu-
lating the QUICKI (quantitative insulin
check index) measure of insulin sensitiv-
ity (8). The equation for QUICKI, 1/{[log
(fasting insulin mU/mL) + log(fasting glu-
cosemg/dL)]},useslogtransformationsof
fastingglucose andinsulinmeasurements
and is a steady-state measure with a high
correlation with the gold standard hyper-
insulinemic-euglycemic glucose clamp
(8). In a sensitivity analysis, homeostasis
model assessment of insulin resistance
(HOMA-IR), an alternate assessment of
insulin sensitivity, was also calculated
and reported as 1/HOMA, calculated as
1/[glucose (mmol/L) 3 insulin (mIU/L)/
22.5] (11). As the linear slopes of
HOMA change in relation to varying in-
sulin sensitivities, the reciprocal and log
transformation of HOMA inherent in
QUICKI make it a more ﬂexible measure,
usable in normal weight, overweight, and
the insulin-resistant state of obese indi-
viduals, and more appropriate for the
range of BMI in our population (8,12–
14). A higher numerical value for
1/HOMAorQUICKIreﬂectsgreaterinsu-
lin sensitivity.
Statistical analysis
Statistical analysis was performed using
linearregressionanalysiswithgeneralized
estimating equations with exchangeable
correlations to account for repeated mea-
sures with robust estimation of the vari-
ance. The primary outcome measure is
the change in QUICKI index, represent-
ing the difference between the index
calculated at baseline and after each diet,
respectively. We also modeled fasting
glucose (mg/dL), fasting insulin (mIU/
m L ) ,a n d1 / H O M Ai nas i m i l a rf a s h i o n .
The continuous variables for change in
QUICKI were approximately normally
distributed. There was a high correlation
between QUICKI and 1/HOMA mea-
sures, with a Pearson correlation coefﬁ-
cient of 0.92. At baseline, we assessed
correlations between QUICKI and tradi-
tional cardiovascular disease risk factors
using Pearson correlation coefﬁcients.
T h e r ew e r ef e wd a t am i s s i n g ;o n l y4
out of 164 participants did not complete
all three intervention diets. Only partic-
ipants with complete data were included
in the regression analysis. In the initial
OmniHeart Trial analysis, there was a
change in weight of 1 kg across the ﬁrst
period, although mean end-of-period
weights were similar regardless of diet
intervention. To account for any impact
on insulin sensitivity from this change in
weight and by period, we adjusted for
feeding period. Between-diet compari-
sons were modeled as multiple linear
regression analyses of the difference in
change in QUICKI and 1/HOMA. To as-
sess for carryover, we lagged exposure
by one feeding period and found no
evidence of a statistically signiﬁcant car-
ryover effect. We tested for interaction
between diet and BMI, sex, race, age, and
prediabetes status through interaction
terms, which were insigniﬁcant for all
stated variables. We then performed strat-
iﬁed analyses based on BMI category (nor-
mal, overweight, or obese) and clinical
status of prediabetes or normoglycemia.
As a sensitivity analysis, we modeled the
ﬁrst period in isolation to examine the
effects without preceding intervention.
Further sensitivity analyses demonstrated
that outliers did not have a marked effect
on our regression model.
Basedonaﬁxedsamplesize(n=160),
we estimated minimal detectable differ-
ences in QUICKI of 0.001, assuming a
signiﬁcance level of 0.05 and a power of
80%.Noadjustmentsweremadeformul-
tiple testing. Primary analyses were per-
formed using STATA version 11.1
(StataCorp, College Station, TX). Statisti-
cal signiﬁcance was deﬁned as P , 0.05.
RESULTSdAt baseline, the participants
had a mean age of 54 years; 45% were
women, 55% were African American, and
Table 1dMacronutrient composition of
study diets
Nutrient targets
(kcal %) CARB PROT UNSAT
Carbohydrate 58 48 48
Protein 15 25 15
Fat 27 27 37
Monounsaturated 13 13 21
Polyunsaturated 8 8 10
Saturated 6 6 6
The boldface data signify the macronutrient per-
centage that has been increased for each speciﬁed
diet.
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Gadgil and Associates79% were overweight or obese. Mean BMI
was 30.2 kg/m
2, and mean QUICKI was
0.35. Other baseline characteristics are
reported in Table 2.
In between-diet comparisons, ad-
justed for period effects, the QUICKI
index increased by a mean of 0.005
(95% CI 0.000–0.009) on the UNSAT
diet, compared with the CARB diet (Fig.
1). The PROT diet showed no signiﬁcant
difference, compared with the CARB diet
(20.004 to 0.007) or the UNSAT diet
(20.009 to 0.002) (Table 3). 1/HOMA
index also improved 0.11 (0.03–0.20)
on the UNSAT diet as compared with
the CARB diet. 1/HOMA did not signiﬁ-
cantlydifferbetweenthePROTandCARB
(20.07 to 0.14) or UNSAT and PROT di-
ets (20.05 to 0.20). There were no be-
tween-diet differences for glucose or
insulin (Table 3).
In models adjusting for feeding pe-
riod (Table 3), the UNSAT diet increased
QUICKI by 0.007 (95% CI 0.002–0.012)
from baseline, but there was no change
with the PROT diet (0.004 [20.002 to
0.009]) or CARB diet (0.002 [20.003 to
0.007]). 1/HOMA showed similar diet-
speciﬁc responses with an increase of
0.14 (0.02–0.26) after consumption of
the UNSAT diet, 0.06 (20.002 to
0.009) after the PROT diet, and 0.04
(20.003 to 0.007) after the CARB diet
compared with baseline. Similar ﬁndings
were seen in analyses not adjusted for
feeding period.
At baseline, there was a strong direct
correlation between QUICKI and HDL
cholesterol (P , 0.001) and QUICKI and
BMI (P , 0.0001), and an inverse corre-
lation between QUICKI and triglyceride
level (P , 0.001). The correlation be-
tween baseline QUICKI and systolic and
diastolic blood pressure was present but
less strong (P , 0.04). We found no sig-
niﬁcant correlation between change in
QUICKI and change in weight, change
in systolic or diastolic blood pressure, to-
tal, HDL, or LDL cholesterol, or triglycer-
ides (not presented). The average weight
decrease from baseline was similar across
allthreediets:mean(SD)0.93kg(2.05kg)
afterinterventionwith the CARB diet, 0.90
kg(2.14kg)aftertheUNSATdiet,and1.12
kg (2.09 kg) after the PROT diet.
We adhered to conservative guide-
lines for analysis of subgroups (15), and
as our interaction terms between diet and
BMI,diabetesstatus,age,race,orsexwere
not signiﬁcant, we did not highlight sub-
group results in Table 3. When stratiﬁed
byBMI,normal-weightparticipantsexpe-
rienced an increase in QUICKI with the
UNSAT as compared with the CARB diet
that trended toward signiﬁcance (0.012,
P = 0.06). There was no change in those
who wereoverweight(0.007,P =0.09)or
obese (0.001, P = 0.83). In participants
with prediabetes, deﬁned as a fasting
glucose between 100 and 125 mg/dL,
choice of diet did not alter QUICKI
(0.003, P = 0.48); however, in those
who were normoglycemic, QUICKI
trended toward signiﬁcance with an in-
crease of 0.005 (P = 0.06). There were no
differences in the PROT versus CARB or
UNSAT versus PROT comparisons.
CONCLUSIONSdIn this trial that
enrolled predominantly overweight and
obese individuals, the UNSAT diet in-
creased QUICKI and 1/HOMA to a
greater degree than the CARB diet. The
UNSAT diet increased the QUICKI index
from baseline, whereas the CARB and
PROTdietsdidnot.Theimprovementsin
insulin sensitivity were both statistically
signiﬁcantandclinicallyrelevant,andthis
comparative difference between three
healthy diets has not previously been
demonstrated.
The UNSAT diet is composed of 37%
kilocaloriesfromunsaturatedfat,whichis
similar to Mediterranean-style diets,
which typically include 28–40% of kilo-
caloriesfromfat,mostlyfromunsaturated
sources (16,17). These data suggest that
anisocaloricdietsimilarinmacronutrient
proportions to Mediterranean-style diets
may improve insulin sensitivity in pa-
tients without type 2 diabetes.
A key feature of this study is the
examination of changes in insulin sensi-
tivity by differing macronutrient intake
Table 2dBaseline characteristics of adults
participating in the OmniHeart Trial
Demographics
Study
participants
(n = 164)
Age (years) 53.6 (10.9)
Female sex, n (%) 73 (45)
Race, n (%)
African American 90 (55)
Non-Hispanic white 65 (40)
Other 9 (5)
BMI (kg/m
2) 30.2 (6.1)
BMI category, n (%)
Normal (18.5–24.9 kg/m
2)3 4 ( 2 1 )
Overweight (25–29.9 kg/m
2)5 7 ( 3 4 )
Obese ($30 kg/m
2)7 3 ( 4 5 )
BMI by sex (kg/m
2)
Male 29.2 (5.5)
Female 31.5 (6.5)
Alcohol intake
Any alcohol intake, n (%) 74 (45)
Number of drinks per week 1.91 (3.16)
Means (SD) presented unless otherwise noted.
Figure 1dBetween-diet comparisons of change in QUICKI measure. Change in QUICKI de-
termined by generalized estimating equations. Error bars indicate 95% CIs.
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Macronutrient intake and insulin sensitivitywhile weight was held constant. The
association of weight loss among over-
weightorobeseindividualswithincreases
in insulin sensitivity has been extensively
studied (18–20). For example, in an anal-
ysis of participants in the Women’s
Health Initiative, a similar increase in
QUICKI to what was observed on the
UNSAT diet in our results was seen in
women who lost an average of 1 kg of
body weight (21). In the OmniHeart Trial,
weight change during the three feeding
periods was small and not signiﬁcantly
different between intervention diets.
Thus, the results suggest that reducing
carbohydrate while increasing unsatu-
rated fat in a healthy diet improves insulin
sensitivity in the setting of stable weight.
Interestingly, there was no correspon-
ding improvement when participants
consumed the reduced-carbohydrate,
increased-protein diet. Hence, the im-
provement in insulin sensitivity on
UNSAT appears to result from an increase
inunsaturatedfatratherthanadecreasein
carbohydrate.
We chose QUICKI as our primary
measure of insulin sensitivity. Both
HOMA and QUICKI indices have been
validated as methods to assess insulin
sensitivity in comparison with the gold
standard hyperinsulinemic-euglycemic
glucose clamp (8,11). Although both are
widely used, the log transformations of
fasting insulin and glucose inherent in
the construction of QUICKI allow for a
better correlation with the gold standard
overawiderdistributionoffastinginsulin
values, in both obese and hypertensive
patients (8,12,22). There is evidence to
suggestthatb-celldysfunctionmay occur
prior to changes in fasting insulin or glu-
cose levels (23). Changes in insulin sensi-
tivity revealed by the 1/HOMA and
QUICKI indices may precede clinical di-
agnosis and allow for earlier detection,
and subsequent intervention, of altered
glucose-insulin homeostasis.
Investigations into the effects of un-
saturated fat– or carbohydrate-rich diets
onglycemiccontrolhaveyieldedconﬂict-
ing results. An isocaloric feeding trial of
720 participants demonstrated no differ-
ences in insulin sensitivity after replacing
saturated fatty acids with monounsatu-
rated fats or carbohydrates, regardless of
theglycemic indexof the diet (24). In this
trial, weight was not held constant
throughout the feeding periods. A second
randomized trial, comparing a standard
carbohydrate-rich diet with one high in
fat and reduced carbohydrates, measured
both insulin sensitivity and b-cell func-
tion. It suggested that a higher-fat,
lower-carbohydrate diet may actually
lower b-cell responsiveness, whereas dy-
namic insulin sensitivity measurements
remained unaffected (25). Possible rea-
sons for the difference in results are fewer
total participants who had a higher aver-
age BMI than in our analysis and who
had a signiﬁcant increase in their fasting
glucose measurements.
Our trial tested moderate, achievable
differencesinmacronutrients,rather than
more extreme changes, such as carbohy-
drate elimination or ketogenic diets. A
high-fat, low-protein, very-low-carbohy-
drate diet has attracted considerable at-
tention, particularly in the lay press.
Although often leading to substantial
weight loss, the ketogenic diet, as an ex-
treme of fat-predominant macronutrient
composition, may actually be detrimental
to overall insulin sensitivity. In animal
studies, dynamic measures of insulin
sensitivity have shown an increase in
hepatic insulin resistance after consump-
tion of ketogenic diets (26,27).
Nutrients, other than carbohydrates
and unsaturated fat, and behavioral fac-
tors might inﬂuence insulin sensitivity.
Saturated fatty acids decrease responsive-
ness of the cell membrane to insulin-
mediated actions through a decrease in
binding afﬁnity, which contributes to
increased insulin resistance (28). High
protein intake, especially from animal-
based sources, has been associated with
an increase in type 2 diabetes risk (29–
31). The European Prospective Investiga-
tionintoCancerandNutrition(EPIC-NL)
study,alarge,prospectiveinvestigationof
38,094 participants, suggests a 30% in-
crease in type 2 diabetes risk with con-
sumption of ﬁve energy percent of
protein in the place of fat or carbohydrate
(32). The same association was not seen
for vegetable protein. Although the PROT
dietinourstudydidnotexceed25%kilo-
calories of total calories from protein, the
increase in both vegetable and animal
sources of protein may be responsible
for the null effect observed in our study.
AlldietsintheOmniHeartTrialwerehigh
in ﬁber, with a nutrient target of .30 g
per day in each diet. Physical activity and
alcohol consumption were constant for
each participant throughout the trial.
Impaired insulin sensitivity in the
obese may attenuate substantial changes
in insulin sensitivity brought about by
changes in macronutrient intake (33). In
our subgroup analyses stratiﬁed by
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Gadgil and Associatesweight category, we found that change in
QUICKIafterconsumptionoftheUNSAT
diet was most pronounced in participants
of normal weight,and the effect decreases
as weight increases. Similarly, partici-
pants adhering to the Mediterranean diet
intheEuropeanProspectiveInvestigation
into Cancer and Nutrition (EPIC-NL) co-
hortdemonstratedslightlydecreasedtype
2d i a b e t e sr i s ka sc o m p a r e dw i t ht h o s e
with low adherence; however, this asso-
ciation was less robust for those who
were obese and ,50 years of age (34).
It is likely that the choice of macronutri-
enttopreventinsulinresistanceandtype
2 diabetes is less important than overall
weight loss in the obese, whereas partial
replacement of carbohydrates by unsat-
urated fat intake can mitigate risk in
those of normal weight. In light of recent
evidence suggesting that diabetes in
those of normal weight leads to higher
mortality (35), altering macronutrient
intake may be another tool in a limited
arsenal to combat risk of cardiovascular
disease and diabetes in those of normal
weight.
The main OmniHeart Trial evaluated
these three healthy diets differing in
macronutrient composition and their
comparative effects on blood pressure
and lipids (7). Compared with the CARB
diet, which lowered blood pressure and
cholesterol from baseline, consumption
of the PROT and UNSAT diets further re-
duced systolic and diastolic blood pres-
sure, and the PROT diet resulted in the
greatestreductioninLDLcholesterol.Ad-
ditionally, compared with the CARB diet,
there was a greater reduction in triglycer-
ides with consumption of both the PROT
and UNSAT diets, and the UNSAT diet
comparatively increased HDL. In a sec-
ondary analysis of this trial, the PROT
diet reduced harmful apolipoprotein
C-III more than the CARB diet and was
found to be more effective in white par-
ticipants than black participants (36,37).
Another analysis reported associations
between the UNSAT diet and improve-
ment of high-molecular-weight and total
a d i p o n e c t i nw h e nc o m p a r e dw i t ht h e
CARB or PROT diets (38). Taken to-
gether, these ﬁndings suggest that partial
replacement ofcarbohydratesbeneﬁcially
affects three major components of the
metabolic syndrome: systolic blood pres-
sure, triglycerides, and HDL cholesterol.
In this context, the increases in insulin
sensitivity with the UNSAT diet demon-
strated with our investigation may serve
as further evidence for its place in the
preventionoftype2diabetesandthemet-
abolic syndrome.
These results should be viewed in the
context of nutrition recommendations
and usual dietary intake. Although the
American Diabetes Association does not
recommend a low-carbohydrate diet,
other institutes prominent in diabetes
care do advocate for carbohydrate com-
position of 40%, with replacement of a
portion of carbohydrate with unsaturated
fat or protein (39). The average carbohy-
drate consumption in the U.S., as col-
lected by the 2005–2006 National
Health and Nutrition Examination Sur-
vey, was ;48% for males and 50% for
females (40). In comparison, the Omni-
HeartCARBdietprovided58%ofkilocal-
ories from carbohydrate, and the UNSAT
diet provided 48% of kilocalories from
carbohydrate.
Our study does have limitations.
First, the period on each diet was only 6
weeks. However, prior feeding studies by
our group have shown that blood pres-
sure and lipid responses occur quickly,
within2–4weeksofadietarychange.Sec-
ond, we assessed insulin sensitivity
through the use of fasting indices, rather
than the gold standard physiologic
clamps. In the absence of dynamic mea-
surements, we have several measures of
insulin sensitivity, and QUICKI appears
the best suited for our population
(8,14,22). Third, insulin sensitivity is
only a surrogate outcome; correlations
with clinical outcomes such as incident
type 2 diabetes or clinical complications
related to insulin sensitivity were not as-
sessed. The strengths of our trial remain
that it is a large, randomized, tightly
controlled feeding study that enrolled a
diverse population. Our subgroup anal-
yses, although provocative, rely on
numbers of participants that are too
small to effectively draw bold conclu-
sions, and the assessments for interac-
tion do not meet the criteria for
statistical signiﬁcance.
In conclusion, our analysis suggests
that a diet rich in unsaturated fats, which
is commonplace in Mediterranean-style
diets, improves insulinsensitivityina pop-
ulation at risk for cardiovascular disease.
Given the well-recognized challenges of
sustaining weight loss, our results suggest
an alternative approach to improving in-
sulin sensitivity.
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